Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The ...
| Metric Name | Value | Trend | |
|---|---|---|---|
| Dividend Yield | 1.3% | ||
| P/E Ratio | 25.8x | ||
| Revenue | 13.009 B | ||
| Net Income to Company | 747.1 M |
| LH | Peers | Sector | |
|---|---|---|---|
Market Cap | 19.253 B | 5.324 B | 64.31 M |
Price % of 52 Week High | 88.8% | 71.6% | 62.1% |
Dividend Yield | 1.3% | 0.0% | 0.0% |
Shareholder Yield | -4.4% | -2.3% | -0.7% |
1 Year Price Total Return | 6.6% | -6.4% | -12.1% |
Beta (5 Year) | 1.11 | 1.01 | 0.64 |
| (presentment in millions) | Trailing Twelve Months | Fiscal Quarters | |||
|---|---|---|---|---|---|
| Period Ending | Dec-22 | Dec-23 | Dec-24 | Dec-23 | Dec-24 |
| Income Statement | |||||
| Revenue | 11,864 | 12,162 | 13,009 | 3,033 | 3,329 |
| Operating Income | 1,752 | 1,113 | 1,138 | 218 | 231 |
| Net Profit | 1,279 | 418 | 746 | (167) | 143 |
| Diluted EPS | 10.94 | 4.33 | 8.84 | -1.97 | 1.71 |
| EBITDA | 2,222 | 1,621 | 1,701 | 295 | 321 |
| Balance Sheet | |||||
| Cash & ST Invest. | 321 | 537 | 1,519 | 537 | 1,519 |
| Current Assets | 4,625 | 3,765 | 4,807 | 3,765 | 4,807 |
| Total Assets | 20,155 | 16,725 | 18,379 | 16,725 | 18,379 |
| Current Liabilities | 3,079 | 3,225 | 3,330 | 3,225 | 3,330 |
| Total Liabilities | 10,040 | 8,835 | 10,313 | 8,835 | 10,313 |
| Total Equity | 10,116 | 7,891 | 8,067 | 7,891 | 8,067 |
| Total Debt | 6,246 | 6,024 | 7,350 | 6,024 | 7,350 |
| Cash Flow Statement | |||||
| Cash Flow Operations | 1,847 | 1,328 | 1,586 | 580 | 777 |
| Cash From Investing | (1,652) | (1,172) | (1,367) | (331) | (210) |
| Cash From Financing | (1,322) | (59) | 780 | (447) | (547) |
| Free Cash Flow | 1,417 | 874 | 1,096 | 412 | 665 |